Global Sofosbuvir (CAS 1190307-88-0) Professional Survey Report 2022, Forecast to 2027

Code: RW00014805634
Multimarket Insight
Aug-2022
Chemicals & Materials
103 Pages

Potent inhibitor of viral RNA polymerase called non-structural protein 5B (NS5B). This nucleotide analog is effective against Hepatitis C virus (HCV) infection since it inhibits viral RNA replication.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Sofosbuvir (CAS 1190307-88-0) industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
Purity ? 98%
Purity ? 98%

Market Segment by Product Application
Adults Patients
Elderly Patients

Finally, the report provides detailed profile and data information analysis of leading company.
Teva Pharmaceutical Industries Ltd
Shanghai Haoyuan Chemexpress Co.
Beaukev Pharma International Pvt.Ltd
DONG BANG FUTURE TECH & LIFE CO.
Anhui HaiKang Pharmaceutical Co. Ltd
LTD
Beijing Kawin Technology Share-holding Co
Tecoland
DEAFARMA
Ltd
Hangzhou Longshine Bio-Tech Co

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Sofosbuvir (CAS 1190307-88-0) consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Sofosbuvir (CAS 1190307-88-0) market by identifying its various subsegments.
3.Focuses on the key global Sofosbuvir (CAS 1190307-88-0) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Sofosbuvir (CAS 1190307-88-0) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Sofosbuvir (CAS 1190307-88-0) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Sofosbuvir (CAS 1190307-88-0) Professional Survey Report Report 2022, Forecast to 2027

1 Market Study Overview
1.1 Study Objectives
1.2 Sofosbuvir (CAS 1190307-88-0) Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Sofosbuvir (CAS 1190307-88-0) Segment by Type
2.1.1 Purity ? 98%
2.1.2 Purity ? 98%
2.2 Market Analysis by Application
2.2.1 Adults Patients
2.2.2 Elderly Patients
2.3 Global Sofosbuvir (CAS 1190307-88-0) Market Comparison by Regions (2017-2027)
2.3.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size (2017-2027)
2.3.2 North America Sofosbuvir (CAS 1190307-88-0) Status and Prospect (2017-2027)
2.3.3 Europe Sofosbuvir (CAS 1190307-88-0) Status and Prospect (2017-2027)
2.3.4 Asia-pacific Sofosbuvir (CAS 1190307-88-0) Status and Prospect (2017-2027)
2.3.5 South America Sofosbuvir (CAS 1190307-88-0) Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Sofosbuvir (CAS 1190307-88-0) Industry Impact
2.5.1 Sofosbuvir (CAS 1190307-88-0) Business Impact Assessment - Covid-19
2.5.2 Market Trends and Sofosbuvir (CAS 1190307-88-0) Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Sofosbuvir (CAS 1190307-88-0) Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Sofosbuvir (CAS 1190307-88-0) Manufacturer Market Share
3.5 Top 10 Sofosbuvir (CAS 1190307-88-0) Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Sofosbuvir (CAS 1190307-88-0) Market
3.7 Key Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of Sofosbuvir (CAS 1190307-88-0) Industry Key Manufacturers
4.1 Teva Pharmaceutical Industries Ltd
4.1.1 Company Details
4.1.2 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification
4.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Teva Pharmaceutical Industries Ltd News
4.2 Shanghai Haoyuan Chemexpress Co.
4.2.1 Company Details
4.2.2 Shanghai Haoyuan Chemexpress Co. Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification
4.2.3 Shanghai Haoyuan Chemexpress Co. Sofosbuvir (CAS 1190307-88-0) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Shanghai Haoyuan Chemexpress Co. News
4.3 Beaukev Pharma International Pvt.Ltd
4.3.1 Company Details
4.3.2 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification
4.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Beaukev Pharma International Pvt.Ltd News
4.4 DONG BANG FUTURE TECH & LIFE CO.
4.4.1 Company Details
4.4.2 DONG BANG FUTURE TECH & LIFE CO. Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification
4.4.3 DONG BANG FUTURE TECH & LIFE CO. Sofosbuvir (CAS 1190307-88-0) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 DONG BANG FUTURE TECH & LIFE CO. News
4.5 Anhui HaiKang Pharmaceutical Co. Ltd
4.5.1 Company Details
4.5.2 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification
4.5.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Anhui HaiKang Pharmaceutical Co. Ltd News
4.6 LTD
4.6.1 Company Details
4.6.2 LTD Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification
4.6.3 LTD Sofosbuvir (CAS 1190307-88-0) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 LTD News
4.7 Beijing Kawin Technology Share-holding Co
4.7.1 Company Details
4.7.2 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification
4.7.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Beijing Kawin Technology Share-holding Co News
4.8 Tecoland
4.8.1 Company Details
4.8.2 Tecoland Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification
4.8.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Tecoland News
4.9 DEAFARMA
4.9.1 Company Details
4.9.2 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification
4.9.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 DEAFARMA News
4.10 Ltd
4.10.1 Company Details
4.10.2 Ltd Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification
4.10.3 Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Ltd News
4.11 Hangzhou Longshine Bio-Tech Co
4.11.1 Company Details
4.11.2 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification
4.11.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Hangzhou Longshine Bio-Tech Co News

5 Global Sofosbuvir (CAS 1190307-88-0) Sales Categorized by Regions
5.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue, Sales and Market Share by Regions
5.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Regions (2017-2022)
5.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Regions (2017-2022)
5.2 North America Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
5.3 Europe Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
5.5 South America Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)

6 North America Sofosbuvir (CAS 1190307-88-0) Market Size Categorized by Countries
6.1 North America Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Countries
6.1.1 North America Sofosbuvir (CAS 1190307-88-0) Sales (Volume) by Countries (2017-2022)
6.1.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2017-2022)
6.1.3 United States Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
6.1.4 Canada Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
6.1.5 Mexico Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
6.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue (Value) by Manufacturers
6.3 North America Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Type (2017-2022)
6.4 North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2022)

7 Europe Sofosbuvir (CAS 1190307-88-0) Market Size Categorized by Countries
7.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Countries
7.1.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2017-2022)
7.1.3 Germany Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
7.1.4 UK Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
7.1.5 France Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
7.1.6 Russia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
7.1.7 Italy Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
7.1.8 Spain Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
7.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue (Value) by Manufacturers
7.3 Europe Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Type (2017-2022)
7.4 Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2022)

8 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Market Size Categorized by Countries
8.1 Asia-pacific Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Sofosbuvir (CAS 1190307-88-0) Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2017-2022)
8.1.3 China Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
8.1.4 South Korea Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
8.1.5 Japan Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
8.1.6 Australia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
8.1.7 India Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Sofosbuvir (CAS 1190307-88-0) Revenue (Value) by Manufacturers
8.3 Asia-pacific Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2022)

9 South America Sofosbuvir (CAS 1190307-88-0) Market Size Categorized by Countries
9.1 South America Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Countries
9.1.1 South America Sofosbuvir (CAS 1190307-88-0) Sales (Volume) by Countries (2017-2022)
9.1.2 South America Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2017-2022)
9.1.3 Brazil Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
9.2 South America Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Type (2017-2022)
9.3 South America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2022)

10 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Size Categorized by Countries
10.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2017-2022)
10.1.3 GCC Countries Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
10.1.4 Turkey Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
10.1.5 Egypt Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
10.1.6 South America Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Type
10.3 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2022)

11 Global Sofosbuvir (CAS 1190307-88-0) Market Segment by Type
11.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Type (2017-2022)
11.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Type (2017-2022)
11.2 Purity ? 98% Sales Growth Rate and Price
11.2.1 Global Purity ? 98% Sales Growth Rate (2017-2022)
11.2.2 Global Purity ? 98% Price (2017-2022)
11.3 Purity ? 98% Sales Growth Rate and Price
11.3.1 Global Purity ? 98% Sales Growth Rate (2017-2022)
11.3.2 Global Purity ? 98% Price (2017-2022)

12 Global Sofosbuvir (CAS 1190307-88-0) Market Segment by Application
12.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2022)
12.2 Adults Patients Sales Growth Rate (2017-2022)
12.3 Elderly Patients Sales Growth Rate (2017-2022)

13 Global Sofosbuvir (CAS 1190307-88-0) Market Forecast
13.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue, Sales and Growth Rate (2022-2027)
13.2 Sofosbuvir (CAS 1190307-88-0) Market Forecast by Regions (2022-2027)
13.2.1 North America Sofosbuvir (CAS 1190307-88-0) Market Forecast (2022-2027)
13.2.2 Europe Sofosbuvir (CAS 1190307-88-0) Market Forecast (2022-2027)
13.2.3 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Market Forecast (2022-2027)
13.2.4 South America Sofosbuvir (CAS 1190307-88-0) Market Forecast (2022-2027)
13.2.5 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Market Forecast (2022-2027)
13.3 Sofosbuvir (CAS 1190307-88-0) Market Forecast by Type (2022-2027)
13.3.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Type (2022-2027)
13.3.2 Global Sofosbuvir (CAS 1190307-88-0) Market Share Forecast by Type (2022-2027)
13.4 Sofosbuvir (CAS 1190307-88-0) Market Forecast by Application (2022-2027)
13.4.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Application (2022-2027)
13.4.2 Global Sofosbuvir (CAS 1190307-88-0) Market Share Forecast by Application (2022-2027)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Sofosbuvir (CAS 1190307-88-0) Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Sofosbuvir (CAS 1190307-88-0) Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures

Figure Product Picture Sofosbuvir (CAS 1190307-88-0)
Figure Market Concentration Ratio and Market Maturity Analysis of Sofosbuvir (CAS 1190307-88-0)
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Sofosbuvir (CAS 1190307-88-0) Market Size by Type
Figure Global Market Share of Sofosbuvir (CAS 1190307-88-0) by Type in 2021
Figure Purity ? 98% Picture
Figure Purity ? 98% Picture
Table Global Sofosbuvir (CAS 1190307-88-0) Market Size (Volume) by Application
Figure Adults Patients Picture
Figure Elderly Patients Picture
Table Global Sofosbuvir (CAS 1190307-88-0) Comparison by Regions (M USD) 2017-2027
Figure Global Sofosbuvir (CAS 1190307-88-0) Market Size (Million US$) (2017-2027)
Figure North America Sofosbuvir (CAS 1190307-88-0) Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Sofosbuvir (CAS 1190307-88-0) Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Sofosbuvir (CAS 1190307-88-0) Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Sofosbuvir (CAS 1190307-88-0) Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Sofosbuvir (CAS 1190307-88-0) Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturer (2017-2022)
Figure Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Manufacturer in 2021
Table Global Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturer (2017-2022)
Figure Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Manufacturer in 2021
Table Global Sofosbuvir (CAS 1190307-88-0) Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Sofosbuvir (CAS 1190307-88-0) Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Sofosbuvir (CAS 1190307-88-0) Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Sofosbuvir (CAS 1190307-88-0) Market
Table Key Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Type
Table Mergers & Acquisitions Planning
Table Teva Pharmaceutical Industries Ltd Company Profile
Table Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification of Teva Pharmaceutical Industries Ltd
Table Sofosbuvir (CAS 1190307-88-0) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Teva Pharmaceutical Industries Ltd 2017-2022
Table Teva Pharmaceutical Industries Ltd Main Business
Table Teva Pharmaceutical Industries Ltd Recent Development
Table Shanghai Haoyuan Chemexpress Co. Company Profile
Table Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification of Shanghai Haoyuan Chemexpress Co.
Table Sofosbuvir (CAS 1190307-88-0) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Shanghai Haoyuan Chemexpress Co. 2017-2022
Table Shanghai Haoyuan Chemexpress Co. Main Business
Table Shanghai Haoyuan Chemexpress Co. Recent Development
Table Beaukev Pharma International Pvt.Ltd Company Profile
Table Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification of Beaukev Pharma International Pvt.Ltd
Table Sofosbuvir (CAS 1190307-88-0) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Beaukev Pharma International Pvt.Ltd 2017-2022
Table Beaukev Pharma International Pvt.Ltd Main Business
Table Beaukev Pharma International Pvt.Ltd Recent Development
Table DONG BANG FUTURE TECH & LIFE CO. Company Profile
Table Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification of DONG BANG FUTURE TECH & LIFE CO.
Table Sofosbuvir (CAS 1190307-88-0) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of DONG BANG FUTURE TECH & LIFE CO. 2017-2022
Table DONG BANG FUTURE TECH & LIFE CO. Main Business
Table DONG BANG FUTURE TECH & LIFE CO. Recent Development
Table Anhui HaiKang Pharmaceutical Co. Ltd Company Profile
Table Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification of Anhui HaiKang Pharmaceutical Co. Ltd
Table Sofosbuvir (CAS 1190307-88-0) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Anhui HaiKang Pharmaceutical Co. Ltd 2017-2022
Table Anhui HaiKang Pharmaceutical Co. Ltd Main Business
Table Anhui HaiKang Pharmaceutical Co. Ltd Recent Development
Table LTD Company Profile
Table Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification of LTD
Table Sofosbuvir (CAS 1190307-88-0) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of LTD 2017-2022
Table LTD Main Business
Table LTD Recent Development
Table Beijing Kawin Technology Share-holding Co Company Profile
Table Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification of Beijing Kawin Technology Share-holding Co
Table Sofosbuvir (CAS 1190307-88-0) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Beijing Kawin Technology Share-holding Co 2017-2022
Table Beijing Kawin Technology Share-holding Co Main Business
Table Beijing Kawin Technology Share-holding Co Recent Development
Table Tecoland Company Profile
Table Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification of Tecoland
Table Sofosbuvir (CAS 1190307-88-0) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Tecoland 2017-2022
Table Tecoland Main Business
Table Tecoland Recent Development
Table DEAFARMA Company Profile
Table Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification of DEAFARMA
Table Sofosbuvir (CAS 1190307-88-0) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of DEAFARMA 2017-2022
Table DEAFARMA Main Business
Table DEAFARMA Recent Development
Table Ltd Company Profile
Table Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification of Ltd
Table Sofosbuvir (CAS 1190307-88-0) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ltd 2017-2022
Table Ltd Main Business
Table Ltd Recent Development
Table Hangzhou Longshine Bio-Tech Co Company Profile
Table Sofosbuvir (CAS 1190307-88-0) Product Introduction, Application and Specification of Hangzhou Longshine Bio-Tech Co
Table Sofosbuvir (CAS 1190307-88-0) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hangzhou Longshine Bio-Tech Co 2017-2022
Table Hangzhou Longshine Bio-Tech Co Main Business
Table Hangzhou Longshine Bio-Tech Co Recent Development
Figure Global Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Global Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2022)
Table Global Sofosbuvir (CAS 1190307-88-0) Sales by Regions (2017-2022)
Figure Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Regions in 2021
Table Global Sofosbuvir (CAS 1190307-88-0) Revenue by Regions (2017-2022)
Figure Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Regions in 2021
Figure North America Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Europe Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Asia-pacific Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure South America Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure North America Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2022)
Table North America Sofosbuvir (CAS 1190307-88-0) Sales (Volume) by Countries (2017-2022)
Table North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries (2017-2022)
Figure North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries in 2021
Table North America Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2017-2022)
Table North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries (2017-2022)
Figure North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries in 2021
Figure United States Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Canada Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Mexico Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Table North America Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturer (2021)
Figure North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Manufacturer in 2021
Table North America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022)
Table North America Sofosbuvir (CAS 1190307-88-0) Sales Share by Type (2017-2022)
Table North America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022)
Table North America Sofosbuvir (CAS 1190307-88-0) Sales Share by Application (2017-2022)
Figure Europe Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2022)
Table Europe Sofosbuvir (CAS 1190307-88-0) Sales (Volume) by Countries (2017-2022)
Table Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries (2017-2022)
Figure Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries in 2021
Table Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2017-2022)
Table Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries (2017-2022)
Figure Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries in 2021
Figure Germany Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure UK Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure France Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Russia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Italy Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Spain Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Table Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturer (2021)
Figure Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Manufacturer in 2021
Table Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022)
Table Europe Sofosbuvir (CAS 1190307-88-0) Sales Share by Type (2017-2022)
Table Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022)
Table Europe Sofosbuvir (CAS 1190307-88-0) Sales Share by Application (2017-2022)
Figure Asia-pacific Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2022)
Table Asia-pacific Sofosbuvir (CAS 1190307-88-0) Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries in 2021
Table Asia-pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2017-2022)
Table Asia-pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries in 2021
Figure China Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure South Korea Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Japan Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Australia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure India Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Southeast Asia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Table Asia-pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturer (2021)
Figure Asia-pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022)
Table Asia-pacific Sofosbuvir (CAS 1190307-88-0) Sales Share by Type (2017-2022)
Table Asia-pacific Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022)
Table Asia-pacific Sofosbuvir (CAS 1190307-88-0) Sales Share by Application (2017-2022)
Figure South America Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2022)
Table South America Sofosbuvir (CAS 1190307-88-0) Sales (Volume) by Countries (2017-2022)
Table South America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries (2017-2022)
Figure South America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries in 2019
Table South America Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2017-2022)
Table South America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries (2017-2022)
Figure South America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries in 2019
Figure Brazil Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Table South America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022)
Table South America Sofosbuvir (CAS 1190307-88-0) Sales Share by Type (2017-2022)
Table South America Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2022)
Table South America Sofosbuvir (CAS 1190307-88-0) Revenue Share by Type (2017-2022)
Table South America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022)
Table South America Sofosbuvir (CAS 1190307-88-0) Sales Share by Application (2017-2022)
Figure Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries in 2019
Table Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2017-2022)
Table Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries in 2019
Figure GCC Countries Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Turkey Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure Egypt Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Figure South Africa Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2017-2022)
Table Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022)
Table Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Share by Type (2017-2022)
Table Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2022)
Table Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Share by Type (2017-2022)
Table Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022)
Table Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Share by Application (2017-2022)
Table Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2017-2022)
Table Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2017-2022)
Figure Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type in 2021
Table Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2017-2022)
Table Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2017-2022)
Figure Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type in 2019
Figure Global Purity ? 98% Sales Growth Rate (2017-2022)
Figure Global Purity ? 98% Price (2017-2022)
Figure Global Purity ? 98% Sales Growth Rate (2017-2022)
Figure Global Purity ? 98% Price (2017-2022)
Table Global Sofosbuvir (CAS 1190307-88-0) Sales by Application (2017-2022)
Table Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2017-2022)
Figure Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application in 2021
Figure Global Adults Patients Sales Growth Rate (2017-2022)
Figure Global Elderly Patients Sales Growth Rate (2017-2022)
Figure Global Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2022-2027)
Figure Global Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2022-2027)
Table Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Regions (2017-2022)
Table Global Sofosbuvir (CAS 1190307-88-0) Market Share Forecast by Regions (2017-2022)
Figure North America Sales Sofosbuvir (CAS 1190307-88-0) Market Forecast (2022-2027)
Figure Europe Sales Sofosbuvir (CAS 1190307-88-0) Market Forecast (2022-2027)
Figure Asia-Pacific Sales Sofosbuvir (CAS 1190307-88-0) Market Forecast (2022-2027)
Figure South America Sales Sofosbuvir (CAS 1190307-88-0) Market Forecast (2022-2027)
Figure Middle East & Africa Sales Sofosbuvir (CAS 1190307-88-0) Market Forecast (2022-2027)
Table Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Type (2022-2027)
Table Global Sofosbuvir (CAS 1190307-88-0) Market Share Forecast by Type (2022-2027)
Table Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Application (2022-2027)
Table Global Sofosbuvir (CAS 1190307-88-0) Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sofosbuvir (CAS 1190307-88-0)
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Graphitized Carbon Black (GCB) Ma.. Graphitized carbon black is a black particle that can be use..

Global Melamine Particle Boards Market G.. The base material of melamine particle board is made of wood..

Global Spherical Molded Glass Lens Marke.. The global market for Spherical Molded Glass Lens is estimat..

Global Aspherical Molded Glass Lens Mark.. The global market for Aspherical Molded Glass Lens is estima..

Global Molded Glass Lens Market Growth 2.. The global market for Molded Glass Lens is estimated to incr..

Global Infrared Chalcogenide Glass Marke.. The global market for Infrared Chalcogenide Glass is estimat..

Global Near-Infrared (NIR) Cutoff Filter.. The global market for Near-Infrared (NIR) Cutoff Filters is ..

Global Infrared Transmitting Filters Mar.. The global market for Infrared Transmitting Filters is estim..

Global Infrared Cut-off Filter Glass Mar.. The global market for Infrared Cut-off Filter Glass is estim..

Global NIR Cut-off Filter Glass Market G.. The global market for NIR Cut-off Filter Glass is estimated ..

Global Carbon Fiber for Pressure Vessel .. The global market for Carbon Fiber for Pressure Vessel is es..

Global Infrared Optical Glass Market Gro.. The global market for Infrared Optical Glass is estimated to..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE